Salts and crystal forms of omecamtiv mecarbil

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11926592
APP PUB NO 20230108971A1
SERIAL NO

17929645

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AMGEN INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caille, Sebastien Thousand Oaks, US 19 102
Cui, Sheng Thousand Oaks, US 23 90
Golightly, Alisa Tranent, GB 1 3
Kelly, Ron C Thousand Oaks, US 14 45
Morrison, Henry Thousand Oaks, US 26 145
Pearson, David Berwichshire, GB 56 433
Quan, Bin Peter Thousand Oaks, US 5 46
Quasdorf, Kyle Thousand Oaks, US 7 52
Raeburn, Jaclyn Milton, CA 4 15
Xiao, Lingyun Thousand Oaks, US 11 20
Yanez, Evelyn Thousand Oaks, US 2 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 12, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 12, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 12, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00